Australia markets closed

Acasti Pharma Inc. (ACST)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.9000-0.0600 (-2.03%)
As of 02:27PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Cash flows from operating activities
Net income
-38,774
-42,429
-9,819
-19,678
Depreciation & amortisation
18
124
0
924
Deferred income taxes
-9,814
-9,542
-648
-
Stock-based compensation
1,006
1,811
1,337
1,174
Change in working capital
-1,631
181
-2,786
-5,946
Other working capital
-13,579
-15,930
-17,234
-14,388
Other non-cash items
-
-
-
264
Net cash provided by operating activities
-13,571
-15,913
-17,234
-14,319
Cash flows from investing activities
Investments in property, plant and equipment
-
-17
-
-69
Purchases of investments
-6,554
-5,015
-34,929
-9,810
Sales/maturities of investments
5,000
18,185
31,407
21
Net cash used for investing activities
-1,452
13,153
-3,522
-9,858
Cash flows from financing activities
Debt repayment
-1,556
-
-
0
Common stock issued
7,338
304
0
59,332
Other financing activities
-
-
-
-143
Net cash used provided by (used for) financing activities
7,359
304
0
59,490
Net change in cash
-7,696
-2,464
-20,603
36,702
Cash at beginning of period
26,241
30,339
50,942
14,240
Cash at end of period
18,577
27,875
30,339
50,942
Free cash flow
Operating cash flow
-13,571
-15,913
-17,234
-14,319
Capital expenditure
-
-17
-
-69
Free cash flow
-13,579
-15,930
-17,234
-14,388